While significant gains made in the fight against HIV/AIDS in the past decade are encouraging, countries most affected by the pandemic continue to struggle to place enough people on treatment…
Closer to Home: Delivering Antiretroviral Therapy in the Community: Experience From Four Countries in Southern Africa
Recent evidence also demonstrates that treating people early with ART reduces HIV transmission, which further supports the need to increase and sustain access to antiretroviral therapy.
Trading Away Health: How the U.S.’s Intellectual Property Demands for the Trans-Pacific Partnership Agreement Threaten Access to Medicines
The Trans-Pacific Partnership Agreement (TPP) is a regional trade agreement that would impose new IP rules that could severely restrict access to affordable, life-saving medicines for millions of people.
With more than eight million individuals worldwide now receiving antiretroviral therapy (ART), the ability to monitor and optimise treatment effectiveness is key to the success of HIV treatment programmes.
Eight million people in developing countries are on HIV treatment today, but the number of people who need access to HIV medicines is growing. Médecins Sans Frontières’ guide to the prices of AIDS medicines is now in its 15th edition.
Speed Up Scale-Up: Strategies, Tools and Policies to Get the Best HIV Treatment to More People, Sooner
The strategies, tools and policies that have supported the scaling up of treatment during the past decade and those that can address persistent or new challenges.